Core Financial Statements From 2010 to 2024

CLABF Stock  USD 0.1  0.0005  0.52%   
Core One financial statements provide useful quarterly and yearly information to potential Core One Labs investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Core One financial statements helps investors assess Core One's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Core One's valuation are summarized below:
Core One Labs does not presently have any fundamental signals for analysis.
Check Core One financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Core One's main balance sheet or income statement drivers, such as , as well as many indicators such as . Core financial statements analysis is a perfect complement when working with Core One Valuation or Volatility modules.
  
This module can also supplement various Core One Technical models . Check out the analysis of Core One Correlation against competitors.

Core One Labs Company Current Valuation Analysis

Core One's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Core One Current Valuation

    
  23.35 M  
Most of Core One's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Core One Labs is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Core One Labs has a Current Valuation of 23.35 M. This is 99.84% lower than that of the Healthcare sector and 99.5% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 99.86% higher than that of the company.

Core One Labs Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Core One's current stock value. Our valuation model uses many indicators to compare Core One value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Core One competition to find correlations between indicators driving Core One's intrinsic value. More Info.
Core One Labs is number one stock in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Core One's earnings, one of the primary drivers of an investment's value.

About Core One Financial Statements

Core One stakeholders use historical fundamental indicators, such as Core One's revenue or net income, to determine how well the company is positioned to perform in the future. Although Core One investors may analyze each financial statement separately, they are all interrelated. For example, changes in Core One's assets and liabilities are reflected in the revenues and expenses on Core One's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Core One Labs. Please read more on our technical analysis and fundamental analysis pages.
Core One Labs Inc. operates as a biotechnology research and technology life sciences company. Core One Labs Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada. Core One operates under Biotechnology classification in the United States and is traded on OTC Exchange.

Currently Active Assets on Macroaxis

Other Information on Investing in Core Pink Sheet

Core One financial ratios help investors to determine whether Core Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Core with respect to the benefits of owning Core One security.